{"id":62169,"date":"2019-09-30T20:12:43","date_gmt":"2019-09-30T20:12:43","guid":{"rendered":"https:\/\/lmcca.wpengine.com\/?page_id=62169"},"modified":"2019-10-07T13:01:51","modified_gmt":"2019-10-07T13:01:51","slug":"publications-2","status":"publish","type":"page","link":"https:\/\/www.lmc.ca\/fr\/publications-2\/","title":{"rendered":"Publications 2019"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; fullwidth=&#8221;on&#8221; _builder_version=&#8221;3.29.3&#8243; background_image=&#8221;https:\/\/lmc.ca\/wp-content\/uploads\/2019\/09\/datascience.jpg&#8221; fb_built=&#8221;1&#8243; _i=&#8221;0&#8243; _address=&#8221;0&#8243;][et_pb_fullwidth_header title=&#8221;Publications&#8221; text_orientation=&#8221;center&#8221; _builder_version=&#8221;3.29.3&#8243; background_image=&#8221;https:\/\/lmc.ca\/wp-content\/uploads\/2018\/07\/rawpixel-378006-unsplash-copy.jpg&#8221; width=&#8221;100%&#8221; min_height=&#8221;426px&#8221; custom_padding=&#8221;150px||||false|false&#8221; _i=&#8221;0&#8243; _address=&#8221;0.0&#8243;]<\/p>\n<p>[\/et_pb_fullwidth_header][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; fullwidth=&#8221;on&#8221; _builder_version=&#8221;3.29.3&#8243; fb_built=&#8221;1&#8243; _i=&#8221;1&#8243; _address=&#8221;1&#8243;][et_pb_fullwidth_menu menu_id=&#8221;269&#8243; submenu_direction=&#8221;downwards&#8221; fullwidth_menu=&#8221;on&#8221; _builder_version=&#8221;3.29.3&#8243; menu_font=&#8221;|800||on|||||&#8221; menu_text_color=&#8221;#ffffff&#8221; menu_font_size=&#8221;19px&#8221; menu_letter_spacing=&#8221;2px&#8221; background_color=&#8221;#44580e&#8221; text_orientation=&#8221;center&#8221; custom_margin=&#8221;||21px|-2px|false|false&#8221; custom_padding=&#8221;||1px|||&#8221; animation_style=&#8221;fade&#8221; menu_text_shadow_style=&#8221;preset2&#8243; menu_text_shadow_horizontal_length=&#8221;0.17em&#8221; menu_text_shadow_vertical_length=&#8221;-0.15em&#8221; menu_text_shadow_blur_strength=&#8221;0.11em&#8221; box_shadow_style=&#8221;preset6&#8243; box_shadow_horizontal=&#8221;-20px&#8221; box_shadow_vertical=&#8221;-1px&#8221; box_shadow_blur=&#8221;40px&#8221; box_shadow_spread=&#8221;-7px&#8221; box_shadow_color=&#8221;#001c07&#8243; _i=&#8221;0&#8243; _address=&#8221;1.0&#8243;][\/et_pb_fullwidth_menu][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;3.29.3&#8243; min_height=&#8221;51px&#8221; custom_padding=&#8221;1px|||||&#8221; fb_built=&#8221;1&#8243; _i=&#8221;2&#8243; _address=&#8221;2&#8243;][et_pb_row _builder_version=&#8221;3.29.3&#8243; custom_margin=&#8221;-17px|auto||auto||&#8221; custom_padding=&#8221;0px||12px|||&#8221; _i=&#8221;0&#8243; _address=&#8221;2.0&#8243;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;3.29.3&#8243; _i=&#8221;0&#8243; _address=&#8221;2.0.0&#8243;][et_pb_text _builder_version=&#8221;3.29.3&#8243; text_orientation=&#8221;center&#8221; min_height=&#8221;65px&#8221; custom_margin=&#8221;||-54px|||&#8221; custom_padding=&#8221;6px||0px|||&#8221; _i=&#8221;0&#8243; _address=&#8221;2.0.0.0&#8243;]<\/p>\n<h1> 2019 <\/h1>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;3.29.3&#8243; _i=&#8221;1&#8243; _address=&#8221;2.1&#8243;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;3.29.3&#8243; link_option_url=&#8221;https:\/\/lmc.ca\/services\/about-us\/?et_fb=1&#038;PageSpeed=off&#8221; _i=&#8221;0&#8243; _address=&#8221;2.1.0&#8243;][et_pb_post_nav next_text=&#8221;2018 Publications&#8221; _builder_version=&#8221;3.29.3&#8243; title_font=&#8221;|700|||||||&#8221; title_text_color=&#8221;#44580e&#8221; custom_margin=&#8221;-28px|||||&#8221; custom_padding=&#8221;||0px|||&#8221; _i=&#8221;0&#8243; _address=&#8221;2.1.0.0&#8243;][\/et_pb_post_nav][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;3.29.3&#8243; custom_padding=&#8221;6px|||||&#8221; _i=&#8221;2&#8243; _address=&#8221;2.2&#8243;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;3.29.3&#8243; _i=&#8221;0&#8243; _address=&#8221;2.2.0&#8243;][et_pb_divider _builder_version=&#8221;3.29.3&#8243; custom_margin=&#8221;-21px|||||&#8221; _i=&#8221;0&#8243; _address=&#8221;2.2.0.0&#8243;][\/et_pb_divider][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; specialty=&#8221;on&#8221; _builder_version=&#8221;3.29.3&#8243; background_color=&#8221;#ffffff&#8221; min_height=&#8221;208px&#8221; custom_margin=&#8221;-57px|||||&#8221; custom_padding=&#8221;||0px|||&#8221; fb_built=&#8221;1&#8243; _i=&#8221;3&#8243; _address=&#8221;3&#8243;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;|||&#8221; _i=&#8221;0&#8243; _address=&#8221;3.0&#8243; custom_padding__hover=&#8221;|||&#8221;][et_pb_image src=&#8221;https:\/\/lmc.ca\/wp-content\/uploads\/2019\/09\/REALITY.png&#8221; _builder_version=&#8221;3.29.3&#8243; width=&#8221;100%&#8221; min_height=&#8221;165px&#8221; max_height=&#8221;1001px&#8221; custom_margin=&#8221;-98px|-283px||1px|false|false&#8221; custom_padding=&#8221;||27px|0px||&#8221; _i=&#8221;0&#8243; _address=&#8221;3.0.0&#8243;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; specialty_columns=&#8221;2&#8243; _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;|||&#8221; _i=&#8221;1&#8243; _address=&#8221;3.1&#8243; custom_padding__hover=&#8221;|||&#8221;][et_pb_row_inner _builder_version=&#8221;3.29.3&#8243; custom_margin=&#8221;-87px||||false|false&#8221; _i=&#8221;0&#8243; _address=&#8221;3.1.0&#8243;][et_pb_column_inner saved_specialty_column_type=&#8221;1_2&#8243; _builder_version=&#8221;3.29.3&#8243; _i=&#8221;0&#8243; _address=&#8221;3.1.0.0&#8243;][et_pb_text _builder_version=&#8221;3.29.3&#8243; _i=&#8221;0&#8243; _address=&#8221;3.1.0.0.0&#8243;]<\/p>\n<p>This study evaluated real-world clinical outcomes of patients with type 1 diabetes (T1D) and type 2 diabetes (T2D) initiating or transferring to insulin glargine 300 U\/mL (Gla 300) vs insulin glargine 100 U\/mL (Gla-100).<\/p>\n<p>[\/et_pb_text][\/et_pb_column_inner][\/et_pb_row_inner][et_pb_row_inner _builder_version=&#8221;3.29.3&#8243; _i=&#8221;1&#8243; _address=&#8221;3.1.1&#8243;][et_pb_column_inner saved_specialty_column_type=&#8221;1_2&#8243; _builder_version=&#8221;3.29.3&#8243; _i=&#8221;0&#8243; _address=&#8221;3.1.1.0&#8243;][et_pb_button button_url=&#8221;https:\/\/lmc.ca\/wp-content\/uploads\/2019\/09\/REALITY_Abitbol-2019-Can-J-Diabetes.pdf&#8221; url_new_window=&#8221;on&#8221; button_text=&#8221;Find Out More&#8221; _builder_version=&#8221;3.29.3&#8243; custom_margin=&#8221;-48px||||false|false&#8221; _i=&#8221;0&#8243; _address=&#8221;3.1.1.0.0&#8243;][\/et_pb_button][\/et_pb_column_inner][\/et_pb_row_inner][\/et_pb_column][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; specialty=&#8221;on&#8221; _builder_version=&#8221;3.29.3&#8243; min_height=&#8221;246px&#8221; custom_padding=&#8221;0px||0px|||&#8221; fb_built=&#8221;1&#8243; _i=&#8221;4&#8243; _address=&#8221;4&#8243;][et_pb_column type=&#8221;1_2&#8243; specialty_columns=&#8221;2&#8243; _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;|||&#8221; _i=&#8221;0&#8243; _address=&#8221;4.0&#8243; custom_padding__hover=&#8221;|||&#8221;][et_pb_row_inner _builder_version=&#8221;3.29.3&#8243; _i=&#8221;0&#8243; _address=&#8221;4.0.0&#8243;][et_pb_column_inner saved_specialty_column_type=&#8221;1_2&#8243; _builder_version=&#8221;3.29.3&#8243; _i=&#8221;0&#8243; _address=&#8221;4.0.0.0&#8243;][et_pb_text _builder_version=&#8221;3.29.3&#8243; custom_margin=&#8221;|||8px|false|false&#8221; _i=&#8221;0&#8243; _address=&#8221;4.0.0.0.0&#8243;]<\/p>\n<p>The aim of this study was to compare patient-reported outcomes and clinical outcomes in patients who initiated dulaglutide or liraglutide as part of usual clinical therapy.<\/p>\n<p>[\/et_pb_text][\/et_pb_column_inner][\/et_pb_row_inner][et_pb_row_inner _builder_version=&#8221;3.29.3&#8243; custom_margin=&#8221;|||-14px|false|false&#8221; _i=&#8221;1&#8243; _address=&#8221;4.0.1&#8243;][et_pb_column_inner saved_specialty_column_type=&#8221;1_2&#8243; _builder_version=&#8221;3.29.3&#8243; _i=&#8221;0&#8243; _address=&#8221;4.0.1.0&#8243;][et_pb_button button_url=&#8221;https:\/\/lmc.ca\/wp-content\/uploads\/2019\/09\/PROGRESS-Diabetes-Brown-2019-DRCP-1.pdf&#8221; url_new_window=&#8221;on&#8221; button_text=&#8221;Find Out More&#8221; _builder_version=&#8221;3.29.3&#8243; custom_margin=&#8221;-47px|||21px|false|false&#8221; _i=&#8221;0&#8243; _address=&#8221;4.0.1.0.0&#8243;][\/et_pb_button][\/et_pb_column_inner][\/et_pb_row_inner][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;|||&#8221; _i=&#8221;1&#8243; _address=&#8221;4.1&#8243; custom_padding__hover=&#8221;|||&#8221;][et_pb_image src=&#8221;https:\/\/lmc.ca\/wp-content\/uploads\/2019\/09\/PROGRESS.png&#8221; _builder_version=&#8221;3.29.3&#8243; _i=&#8221;0&#8243; _address=&#8221;4.1.0&#8243;][\/et_pb_image][\/et_pb_column][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; specialty=&#8221;on&#8221; _builder_version=&#8221;3.29.3&#8243; min_height=&#8221;406px&#8221; custom_padding=&#8221;0px|||||&#8221; fb_built=&#8221;1&#8243; _i=&#8221;5&#8243; _address=&#8221;5&#8243;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;|||&#8221; _i=&#8221;0&#8243; _address=&#8221;5.0&#8243; custom_padding__hover=&#8221;|||&#8221;][et_pb_image src=&#8221;https:\/\/lmc.ca\/wp-content\/uploads\/2019\/09\/Study-3.png&#8221; _builder_version=&#8221;3.29.3&#8243; min_height=&#8221;188px&#8221; custom_padding=&#8221;|0px||0px||&#8221; _i=&#8221;0&#8243; _address=&#8221;5.0.0&#8243;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; specialty_columns=&#8221;2&#8243; _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;|||&#8221; _i=&#8221;1&#8243; _address=&#8221;5.1&#8243; custom_padding__hover=&#8221;|||&#8221;][et_pb_row_inner _builder_version=&#8221;3.29.3&#8243; _i=&#8221;0&#8243; _address=&#8221;5.1.0&#8243;][et_pb_column_inner saved_specialty_column_type=&#8221;1_2&#8243; _builder_version=&#8221;3.29.3&#8243; _i=&#8221;0&#8243; _address=&#8221;5.1.0.0&#8243;][et_pb_text _builder_version=&#8221;3.29.3&#8243; _i=&#8221;0&#8243; _address=&#8221;5.1.0.0.0&#8243;]<\/p>\n<p>The Skills, Confidence, and Preparedness Index (SCPI) is an electronic tool designed<br \/>\nto assess three dimensions (knowledge, confidence, and preparedness) in a<br \/>\nclinically relevant measure, with immediate feedback to guide the individualization<br \/>\nof patient education. This study sought to assess the validity and reliability of the<br \/>\nfinal SCPI generation, its relevance to glycemia, and its responsiveness to patient<br \/>\neducation.<\/p>\n<p>[\/et_pb_text][\/et_pb_column_inner][\/et_pb_row_inner][et_pb_row_inner _builder_version=&#8221;3.29.3&#8243; _i=&#8221;1&#8243; _address=&#8221;5.1.1&#8243;][et_pb_column_inner saved_specialty_column_type=&#8221;1_2&#8243; _builder_version=&#8221;3.29.3&#8243; _i=&#8221;0&#8243; _address=&#8221;5.1.1.0&#8243;][et_pb_button button_url=&#8221;https:\/\/lmc.ca\/wp-content\/uploads\/2019\/08\/SCPI-3-Aronson-2019-Diabetes-Care.pdf&#8221; url_new_window=&#8221;on&#8221; button_text=&#8221;Find Out More&#8221; _builder_version=&#8221;3.29.3&#8243; custom_margin=&#8221;-51px||||false|false&#8221; _i=&#8221;0&#8243; _address=&#8221;5.1.1.0.0&#8243;][\/et_pb_button][\/et_pb_column_inner][\/et_pb_row_inner][\/et_pb_column][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; specialty=&#8221;on&#8221; _builder_version=&#8221;3.29.3&#8243; custom_margin=&#8221;-155px|||||&#8221; custom_padding=&#8221;42px||0px|||&#8221; fb_built=&#8221;1&#8243; _i=&#8221;6&#8243; _address=&#8221;6&#8243;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;|||&#8221; _i=&#8221;0&#8243; _address=&#8221;6.0&#8243; custom_padding__hover=&#8221;|||&#8221;][et_pb_text _builder_version=&#8221;3.29.3&#8243; _i=&#8221;0&#8243; _address=&#8221;6.0.0&#8243;]<\/p>\n<p>The aim of this study was to assess the reliability of self-perception of glycemia during high-intensity interval training (HIIT) in subjects with type 1 diabetes (T1D).<\/p>\n<p>[\/et_pb_text][et_pb_button button_url=&#8221;https:\/\/lmc.ca\/wp-content\/uploads\/2019\/08\/FIT-study-hypo-symptoms-Potashner-2019-Diabetes-Care-1.pdf&#8221; url_new_window=&#8221;on&#8221; button_text=&#8221;Find Out More&#8221; _builder_version=&#8221;3.29.3&#8243; custom_margin=&#8221;-15px||||false|false&#8221; _i=&#8221;1&#8243; _address=&#8221;6.0.1&#8243;][\/et_pb_button][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; specialty_columns=&#8221;2&#8243; _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;|||&#8221; _i=&#8221;1&#8243; _address=&#8221;6.1&#8243; custom_padding__hover=&#8221;|||&#8221;][et_pb_row_inner _builder_version=&#8221;3.29.3&#8243; _i=&#8221;0&#8243; _address=&#8221;6.1.0&#8243;][et_pb_column_inner saved_specialty_column_type=&#8221;1_2&#8243; _builder_version=&#8221;3.29.3&#8243; _i=&#8221;0&#8243; _address=&#8221;6.1.0.0&#8243;][et_pb_image src=&#8221;https:\/\/lmc.ca\/wp-content\/uploads\/2019\/09\/Study-4.png&#8221; _builder_version=&#8221;3.29.3&#8243; _i=&#8221;0&#8243; _address=&#8221;6.1.0.0.0&#8243;][\/et_pb_image][\/et_pb_column_inner][\/et_pb_row_inner][\/et_pb_column][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; specialty=&#8221;on&#8221; _builder_version=&#8221;3.29.3&#8243; custom_padding=&#8221;||0px|||&#8221; fb_built=&#8221;1&#8243; _i=&#8221;7&#8243; _address=&#8221;7&#8243;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;|||&#8221; _i=&#8221;0&#8243; _address=&#8221;7.0&#8243; custom_padding__hover=&#8221;|||&#8221;][et_pb_image src=&#8221;https:\/\/lmc.ca\/wp-content\/uploads\/2019\/09\/Study-5.png&#8221; _builder_version=&#8221;3.29.3&#8243; min_height=&#8221;157px&#8221; custom_margin=&#8221;-56px|-63px||||&#8221; _i=&#8221;0&#8243; _address=&#8221;7.0.0&#8243;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; specialty_columns=&#8221;2&#8243; _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;|||&#8221; _i=&#8221;1&#8243; _address=&#8221;7.1&#8243; custom_padding__hover=&#8221;|||&#8221;][et_pb_row_inner _builder_version=&#8221;3.29.3&#8243; _i=&#8221;0&#8243; _address=&#8221;7.1.0&#8243;][et_pb_column_inner saved_specialty_column_type=&#8221;1_2&#8243; _builder_version=&#8221;3.29.3&#8243; _i=&#8221;0&#8243; _address=&#8221;7.1.0.0&#8243;][et_pb_text _builder_version=&#8221;3.29.3&#8243; custom_margin=&#8221;-59px||||false|false&#8221; _i=&#8221;0&#8243; _address=&#8221;7.1.0.0.0&#8243;]<\/p>\n<p>Hypomagnesemia (serum magnesium [Mg] b0.74 mmol\/L [b1.8 mg\/dL]) is commonly observed in patients with type 2 diabetes (T2D). This study investigated the effect of treatment with dapagliflozin 10 mg on Mg concentrations in patients with T2D.<\/p>\n<p>[\/et_pb_text][\/et_pb_column_inner][\/et_pb_row_inner][et_pb_row_inner _builder_version=&#8221;3.29.3&#8243; _i=&#8221;1&#8243; _address=&#8221;7.1.1&#8243;][et_pb_column_inner saved_specialty_column_type=&#8221;1_2&#8243; _builder_version=&#8221;3.29.3&#8243; _i=&#8221;0&#8243; _address=&#8221;7.1.1.0&#8243;][et_pb_button button_url=&#8221;https:\/\/lmc.ca\/wp-content\/uploads\/2019\/08\/Dapagliflozin-and-Magnesium-Pooled-Analysis-J-Diab-Compl-2019-copy-2.pdf&#8221; url_new_window=&#8221;on&#8221; button_text=&#8221;Find Out More&#8221; _builder_version=&#8221;3.29.3&#8243; custom_margin=&#8221;-47px||||false|false&#8221; _i=&#8221;0&#8243; _address=&#8221;7.1.1.0.0&#8243;][\/et_pb_button][\/et_pb_column_inner][\/et_pb_row_inner][\/et_pb_column][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; specialty=&#8221;on&#8221; _builder_version=&#8221;3.29.3&#8243; custom_padding=&#8221;0px||16px|||&#8221; fb_built=&#8221;1&#8243; _i=&#8221;8&#8243; _address=&#8221;8&#8243;][et_pb_column type=&#8221;1_2&#8243; specialty_columns=&#8221;2&#8243; _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;|||&#8221; _i=&#8221;0&#8243; _address=&#8221;8.0&#8243; custom_padding__hover=&#8221;|||&#8221;][et_pb_row_inner _builder_version=&#8221;3.29.3&#8243; _i=&#8221;0&#8243; _address=&#8221;8.0.0&#8243;][et_pb_column_inner saved_specialty_column_type=&#8221;1_2&#8243; _builder_version=&#8221;3.29.3&#8243; _i=&#8221;0&#8243; _address=&#8221;8.0.0.0&#8243;][et_pb_text _builder_version=&#8221;3.29.3&#8243; custom_margin=&#8221;8px||||false|false&#8221; _i=&#8221;0&#8243; _address=&#8221;8.0.0.0.0&#8243;]<\/p>\n<p>The aim of this study was to investigate the performance of the Eversense XL implantable continuous glucose monitoring (CGM) system through 180 days in a primarily adolescent population with type 1 diabetes (T1D).<\/p>\n<p>[\/et_pb_text][\/et_pb_column_inner][\/et_pb_row_inner][et_pb_row_inner _builder_version=&#8221;3.29.3&#8243; _i=&#8221;1&#8243; _address=&#8221;8.0.1&#8243;][et_pb_column_inner saved_specialty_column_type=&#8221;1_2&#8243; _builder_version=&#8221;3.29.3&#8243; _i=&#8221;0&#8243; _address=&#8221;8.0.1.0&#8243;][et_pb_button button_url=&#8221;https:\/\/lmc.ca\/wp-content\/uploads\/2019\/05\/Aronson-et-al-2019-Eversense-Pediatric-180-day-study-Diabetes-Obesity-Metabolism-1.pdf&#8221; url_new_window=&#8221;on&#8221; button_text=&#8221;Find Out More&#8221; _builder_version=&#8221;3.29.3&#8243; custom_margin=&#8221;-48px||||false|false&#8221; _i=&#8221;0&#8243; _address=&#8221;8.0.1.0.0&#8243;][\/et_pb_button][\/et_pb_column_inner][\/et_pb_row_inner][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;|||&#8221; _i=&#8221;1&#8243; _address=&#8221;8.1&#8243; custom_padding__hover=&#8221;|||&#8221;][et_pb_image src=&#8221;https:\/\/lmc.ca\/wp-content\/uploads\/2019\/09\/Study-6.png&#8221; _builder_version=&#8221;3.29.3&#8243; width=&#8221;100%&#8221; custom_margin=&#8221;|-23px|3px|||&#8221; _i=&#8221;0&#8243; _address=&#8221;8.1.0&#8243;][\/et_pb_image][\/et_pb_column][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; specialty=&#8221;on&#8221; _builder_version=&#8221;3.29.3&#8243; min_height=&#8221;282px&#8221; custom_margin=&#8221;-11px|||||&#8221; custom_padding=&#8221;0px||1px|||&#8221; fb_built=&#8221;1&#8243; _i=&#8221;9&#8243; _address=&#8221;9&#8243;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;|||&#8221; _i=&#8221;0&#8243; _address=&#8221;9.0&#8243; custom_padding__hover=&#8221;|||&#8221;][et_pb_image src=&#8221;https:\/\/lmc.ca\/wp-content\/uploads\/2019\/09\/Study-7.png&#8221; _builder_version=&#8221;3.29.3&#8243; _i=&#8221;0&#8243; _address=&#8221;9.0.0&#8243;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; specialty_columns=&#8221;2&#8243; _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;|||&#8221; _i=&#8221;1&#8243; _address=&#8221;9.1&#8243; custom_padding__hover=&#8221;|||&#8221;][et_pb_row_inner _builder_version=&#8221;3.29.3&#8243; _i=&#8221;0&#8243; _address=&#8221;9.1.0&#8243;][et_pb_column_inner saved_specialty_column_type=&#8221;1_2&#8243; _builder_version=&#8221;3.29.3&#8243; _i=&#8221;0&#8243; _address=&#8221;9.1.0.0&#8243;][et_pb_text _builder_version=&#8221;3.29.3&#8243; custom_margin=&#8221;1px||||false|false&#8221; _i=&#8221;0&#8243; _address=&#8221;9.1.0.0.0&#8243;]<\/p>\n<p>Postexercise hyperglycemia, following high-intensity interval training (HIIT) in<br \/>\npatients with type 1 diabetes (T1D), is largely underrecognized by the clinical<br \/>\ncommunity and generally undertreated. The aim of this study was to compare four<br \/>\nmultipliers of an individual\u2019s insulin correction factor (ICF) to treat post-HIIT<br \/>\nhyperglycemia.<\/p>\n<p>[\/et_pb_text][\/et_pb_column_inner][\/et_pb_row_inner][et_pb_row_inner _builder_version=&#8221;3.29.3&#8243; _i=&#8221;1&#8243; _address=&#8221;9.1.1&#8243;][et_pb_column_inner saved_specialty_column_type=&#8221;1_2&#8243; _builder_version=&#8221;3.29.3&#8243; _i=&#8221;0&#8243; _address=&#8221;9.1.1.0&#8243;][et_pb_button button_url=&#8221;https:\/\/lmc.ca\/wp-content\/uploads\/2019\/05\/Aronson-et-al-2018-Diabetes-Care-FIT-Study-1.pdf&#8221; url_new_window=&#8221;on&#8221; button_text=&#8221;Find Out More&#8221; _builder_version=&#8221;3.29.3&#8243; custom_margin=&#8221;-45px||||false|false&#8221; _i=&#8221;0&#8243; _address=&#8221;9.1.1.0.0&#8243;][\/et_pb_button][\/et_pb_column_inner][\/et_pb_row_inner][\/et_pb_column][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; specialty=&#8221;on&#8221; _builder_version=&#8221;3.29.3&#8243; custom_padding=&#8221;0px||30px|||&#8221; fb_built=&#8221;1&#8243; _i=&#8221;10&#8243; _address=&#8221;10&#8243;][et_pb_column type=&#8221;1_2&#8243; specialty_columns=&#8221;2&#8243; _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;|||&#8221; _i=&#8221;0&#8243; _address=&#8221;10.0&#8243; custom_padding__hover=&#8221;|||&#8221;][et_pb_row_inner _builder_version=&#8221;3.29.3&#8243; _i=&#8221;0&#8243; _address=&#8221;10.0.0&#8243;][et_pb_column_inner saved_specialty_column_type=&#8221;1_2&#8243; _builder_version=&#8221;3.29.3&#8243; _i=&#8221;0&#8243; _address=&#8221;10.0.0.0&#8243;][et_pb_text _builder_version=&#8221;3.29.3&#8243; custom_margin=&#8221;9px|||5px|false|false&#8221; _i=&#8221;0&#8243; _address=&#8221;10.0.0.0.0&#8243;]<\/p>\n<p>Patients with type 1 diabetes (T1D) often report a rise in their blood glucose level<br \/>\nfollowing brief intense exercise. We sought to determine the reproducibility of the<br \/>\ncardiometabolic responses to high-intensity interval training (HIIT).<\/p>\n<p>[\/et_pb_text][\/et_pb_column_inner][\/et_pb_row_inner][et_pb_row_inner _builder_version=&#8221;3.29.3&#8243; _i=&#8221;1&#8243; _address=&#8221;10.0.1&#8243;][et_pb_column_inner saved_specialty_column_type=&#8221;1_2&#8243; _builder_version=&#8221;3.29.3&#8243; _i=&#8221;0&#8243; _address=&#8221;10.0.1.0&#8243;][et_pb_button button_url=&#8221;https:\/\/lmc.ca\/wp-content\/uploads\/2019\/05\/Riddell-2019_DRCP_Reproducibility-in-the-cardiometabolic-responses-to-HIIT-in-adults-with-T1D.pdf&#8221; url_new_window=&#8221;on&#8221; button_text=&#8221;Find Out More&#8221; _builder_version=&#8221;3.29.3&#8243; custom_margin=&#8221;-51px|||5px|false|false&#8221; _i=&#8221;0&#8243; _address=&#8221;10.0.1.0.0&#8243;][\/et_pb_button][\/et_pb_column_inner][\/et_pb_row_inner][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;|||&#8221; _i=&#8221;1&#8243; _address=&#8221;10.1&#8243; custom_padding__hover=&#8221;|||&#8221;][et_pb_image src=&#8221;https:\/\/lmc.ca\/wp-content\/uploads\/2019\/09\/Study-8.png&#8221; _builder_version=&#8221;3.29.3&#8243; _i=&#8221;0&#8243; _address=&#8221;10.1.0&#8243;][\/et_pb_image][\/et_pb_column][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; specialty=&#8221;on&#8221; _builder_version=&#8221;3.29.3&#8243; custom_margin=&#8221;-21px|||||&#8221; custom_padding=&#8221;0px||0px|||&#8221; fb_built=&#8221;1&#8243; _i=&#8221;11&#8243; _address=&#8221;11&#8243;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;|||&#8221; _i=&#8221;0&#8243; _address=&#8221;11.0&#8243; custom_padding__hover=&#8221;|||&#8221;][et_pb_image src=&#8221;https:\/\/lmc.ca\/wp-content\/uploads\/2019\/09\/Study-9.png&#8221; _builder_version=&#8221;3.29.3&#8243; _i=&#8221;0&#8243; _address=&#8221;11.0.0&#8243;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; specialty_columns=&#8221;2&#8243; _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;|||&#8221; _i=&#8221;1&#8243; _address=&#8221;11.1&#8243; custom_padding__hover=&#8221;|||&#8221;][et_pb_row_inner _builder_version=&#8221;3.29.3&#8243; _i=&#8221;0&#8243; _address=&#8221;11.1.0&#8243;][et_pb_column_inner saved_specialty_column_type=&#8221;1_2&#8243; _builder_version=&#8221;3.29.3&#8243; _i=&#8221;0&#8243; _address=&#8221;11.1.0.0&#8243;][et_pb_text _builder_version=&#8221;3.29.3&#8243; custom_margin=&#8221;-7px||||false|false&#8221; _i=&#8221;0&#8243; _address=&#8221;11.1.0.0.0&#8243;]<\/p>\n<p>This study investigated the accuracy of real-time continuous glucose monitoring (rtCGM) during high intensity interval training (HIIT) in patients with type 1 diabetes (T1D).<\/p>\n<p>[\/et_pb_text][\/et_pb_column_inner][\/et_pb_row_inner][et_pb_row_inner _builder_version=&#8221;3.29.3&#8243; _i=&#8221;1&#8243; _address=&#8221;11.1.1&#8243;][et_pb_column_inner saved_specialty_column_type=&#8221;1_2&#8243; _builder_version=&#8221;3.29.3&#8243; _i=&#8221;0&#8243; _address=&#8221;11.1.1.0&#8243;][et_pb_button button_url=&#8221;https:\/\/lmc.ca\/wp-content\/uploads\/2019\/05\/Untitled-9.pdf&#8221; url_new_window=&#8221;on&#8221; button_text=&#8221;Find Out More&#8221; _builder_version=&#8221;3.29.3&#8243; custom_margin=&#8221;-54px||||false|false&#8221; _i=&#8221;0&#8243; _address=&#8221;11.1.1.0.0&#8243;][\/et_pb_button][\/et_pb_column_inner][\/et_pb_row_inner][\/et_pb_column][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;3.29.3&#8243; min_height=&#8221;19px&#8221; custom_padding=&#8221;||0px|||&#8221; fb_built=&#8221;1&#8243; _i=&#8221;12&#8243; _address=&#8221;12&#8243;][et_pb_row _builder_version=&#8221;3.29.3&#8243; custom_margin=&#8221;-55px|auto|-77px|auto||&#8221; custom_padding=&#8221;||0px|||&#8221; _i=&#8221;0&#8243; _address=&#8221;12.0&#8243;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;3.29.3&#8243; _i=&#8221;0&#8243; _address=&#8221;12.0.0&#8243;][et_pb_divider _builder_version=&#8221;3.29.3&#8243; custom_margin=&#8221;-14px||-24px|||&#8221; custom_padding=&#8221;||0px|||&#8221; _i=&#8221;0&#8243; _address=&#8221;12.0.0.0&#8243;][\/et_pb_divider][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>2019 This study evaluated real-world clinical outcomes of patients with type 1 diabetes (T1D) and type 2 diabetes (T2D) initiating or transferring to insulin glargine 300 U\/mL (Gla 300) vs insulin glargine 100 U\/mL (Gla-100).The aim of this study was to compare patient-reported outcomes and clinical outcomes in patients who initiated dulaglutide or liraglutide as [&hellip;]<\/p>\n","protected":false},"author":25,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","two_page_speed":[],"footnotes":""},"class_list":["post-62169","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Publications 2019 - LMC Healthcare: Helping You Understand and Control your Diabetes<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.lmc.ca\/fr\/publications-2\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Publications 2019 - LMC Healthcare: Helping You Understand and Control your Diabetes\" \/>\n<meta property=\"og:description\" content=\"2019 This study evaluated real-world clinical outcomes of patients with type 1 diabetes (T1D) and type 2 diabetes (T2D) initiating or transferring to insulin glargine 300 U\/mL (Gla 300) vs insulin glargine 100 U\/mL (Gla-100).The aim of this study was to compare patient-reported outcomes and clinical outcomes in patients who initiated dulaglutide or liraglutide as [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.lmc.ca\/fr\/publications-2\/\" \/>\n<meta property=\"og:site_name\" content=\"LMC Healthcare: Helping You Understand and Control your Diabetes\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/LMCDiabetesandEndocrinology\/\" \/>\n<meta property=\"article:modified_time\" content=\"2019-10-07T13:01:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.lmc.ca\/wp-content\/uploads\/2015\/07\/lmc-logo-white.png\" \/>\n\t<meta property=\"og:image:width\" content=\"420\" \/>\n\t<meta property=\"og:image:height\" content=\"101\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@lmc_diabetes\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"12 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.lmc.ca\\\/publications-2\\\/\",\"url\":\"https:\\\/\\\/www.lmc.ca\\\/publications-2\\\/\",\"name\":\"Publications 2019 - LMC Healthcare: Helping You Understand and Control your Diabetes\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.lmc.ca\\\/#website\"},\"datePublished\":\"2019-09-30T20:12:43+00:00\",\"dateModified\":\"2019-10-07T13:01:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.lmc.ca\\\/publications-2\\\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.lmc.ca\\\/publications-2\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.lmc.ca\\\/publications-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.lmc.ca\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Publications 2019\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.lmc.ca\\\/#website\",\"url\":\"https:\\\/\\\/www.lmc.ca\\\/\",\"name\":\"LMC Healthcare: Helping You Understand and Control your Diabetes\",\"description\":\"Consulting Design Engineers\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.lmc.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Publications 2019 - LMC Healthcare: Helping You Understand and Control your Diabetes","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.lmc.ca\/fr\/publications-2\/","og_locale":"fr_CA","og_type":"article","og_title":"Publications 2019 - LMC Healthcare: Helping You Understand and Control your Diabetes","og_description":"2019 This study evaluated real-world clinical outcomes of patients with type 1 diabetes (T1D) and type 2 diabetes (T2D) initiating or transferring to insulin glargine 300 U\/mL (Gla 300) vs insulin glargine 100 U\/mL (Gla-100).The aim of this study was to compare patient-reported outcomes and clinical outcomes in patients who initiated dulaglutide or liraglutide as [&hellip;]","og_url":"https:\/\/www.lmc.ca\/fr\/publications-2\/","og_site_name":"LMC Healthcare: Helping You Understand and Control your Diabetes","article_publisher":"https:\/\/www.facebook.com\/LMCDiabetesandEndocrinology\/","article_modified_time":"2019-10-07T13:01:51+00:00","og_image":[{"width":420,"height":101,"url":"https:\/\/www.lmc.ca\/wp-content\/uploads\/2015\/07\/lmc-logo-white.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@lmc_diabetes","twitter_misc":{"Est. reading time":"12 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.lmc.ca\/publications-2\/","url":"https:\/\/www.lmc.ca\/publications-2\/","name":"Publications 2019 - LMC Healthcare: Helping You Understand and Control your Diabetes","isPartOf":{"@id":"https:\/\/www.lmc.ca\/#website"},"datePublished":"2019-09-30T20:12:43+00:00","dateModified":"2019-10-07T13:01:51+00:00","breadcrumb":{"@id":"https:\/\/www.lmc.ca\/publications-2\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.lmc.ca\/publications-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.lmc.ca\/publications-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.lmc.ca\/"},{"@type":"ListItem","position":2,"name":"Publications 2019"}]},{"@type":"WebSite","@id":"https:\/\/www.lmc.ca\/#website","url":"https:\/\/www.lmc.ca\/","name":"LMC Healthcare : Pour mieux comprendre et ma\u00eetriser votre diab\u00e8te","description":"Ing\u00e9nieurs conseils en conception","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.lmc.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"}]}},"_links":{"self":[{"href":"https:\/\/www.lmc.ca\/fr\/wp-json\/wp\/v2\/pages\/62169","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lmc.ca\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.lmc.ca\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.lmc.ca\/fr\/wp-json\/wp\/v2\/users\/25"}],"replies":[{"embeddable":true,"href":"https:\/\/www.lmc.ca\/fr\/wp-json\/wp\/v2\/comments?post=62169"}],"version-history":[{"count":0,"href":"https:\/\/www.lmc.ca\/fr\/wp-json\/wp\/v2\/pages\/62169\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.lmc.ca\/fr\/wp-json\/wp\/v2\/media?parent=62169"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}